CDH2 and melanoma: However, during melanoma progression, there is a progressive loss of E-cadherin [48,49,50] and gain of N-cadherin [49,51,52,53], which not only frees melanoma cells from control by keratinocytes, but also provides new adhesion characteristics [54,55,56].